Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Galapagos (GLPG) and Thermo Fisher (TMO).
Galapagos (GLPG)
In a report released today, Derek Archila from Stifel Nicolaus reiterated a Hold rating on Galapagos. The company’s shares closed last Thursday at $125.80, close to its 52-week low of $112.00.
According to TipRanks.com, Archila is a 4-star analyst with an average return of 9.6% and a 45.8% success rate. Archila covers the Healthcare sector, focusing on stocks such as DBV Technologies SA – American, Madrigal Pharmaceuticals, and Phasebio Pharmaceuticals.
The word on The Street in general, suggests a Hold analyst consensus rating for Galapagos with a $163.64 average price target.
See today’s analyst top recommended stocks >>
Thermo Fisher (TMO)
In a report released today, Puneet Souda from Leerink Partners maintained a Buy rating on Thermo Fisher, with a price target of $470.00. The company’s shares closed last Thursday at $419.73, close to its 52-week high of $441.96.
According to TipRanks.com, Souda is a 5-star analyst with an average return of 26.3% and a 66.3% success rate. Souda covers the Healthcare sector, focusing on stocks such as Castle Biosciences, Exact Sciences, and T2 Biosystems.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Thermo Fisher with a $459.91 average price target, which is an 8.5% upside from current levels. In a report released today, Needham also maintained a Buy rating on the stock with a $468.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
